The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Salivary proteomic profile of patients with renal cell carcinoma.
 
Adithya Balasubramanian
No Relationships to Disclose
 
Weidong Zhou
No Relationships to Disclose
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Avant Diagnostics; Ceres Nanosciences; Perthera
Consulting or Advisory Role - Avant Diagnostics; AZGen; Ceres Nanosciences; Perthera
Research Funding - Abbvie (Inst); Ceres Nanosciences (Inst); Genentech (Inst); Mirati Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera
 
Charles F. Streckfus
No Relationships to Disclose
 
John R Klein
No Relationships to Disclose
 
Wei Qiao
No Relationships to Disclose
 
Christopher G. Wood
Leadership - Kidney Cancer Association
Honoraria - Argos Therapeutics; Merck; Pfizer
Speakers' Bureau - Argos Therapeutics; Pfizer
Research Funding - Argos Therapeutics; Pfizer
Travel, Accommodations, Expenses - Argos Therapeutics; Merck
 
Jose A. Karam
Stock and Other Ownership Interests - Alimera Sciences; MedTek
Honoraria - Pfizer; Roche/Genentech
Consulting or Advisory Role - Pfizer; Roche/Genentech
Research Funding - Merck (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Marisa Lozano
No Relationships to Disclose
 
Surena F. Matin
Honoraria - Taris BioMedical; Urogen pharma
Consulting or Advisory Role - C-SATS; Peloton Therapeutics; QED Therapeutics; Taris BioMedical
Research Funding - AT&T
Travel, Accommodations, Expenses - MSD